13 - Home | The University of Sheffield

Clinical endpoint efficacy may result from different mechanisms of vaccine action – for example, protection may be good against severe disease and death from COVID-19 but poor at preventing infection with the virus and viral shedding, resulting in a low impact on virus transmission (and little or no prospect of achieving ‘herd immunity ... ................
................